NASDAQ:DRRX DURECT (DRRX) News Today $2.71 -0.11 (-3.90%) (As of 04:24 PM ET) Add Compare Share Share Today's Range$2.68▼$2.8950-Day Range$2.75▼$5.0352-Week Range$2.67▼$9.50Volume141,833 shsAverage Volume157,787 shsMarket Capitalization$74.80 millionP/E RatioN/ADividend YieldN/APrice Target$34.25 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDURECT Co. (NASDAQ:DRRX) Forecasted to Earn Q3 2023 Earnings of ($0.42) Per Shareamericanbankingnews.com - September 18 at 1:20 AMShort Interest in DURECT Co. (NASDAQ:DRRX) Rises By 19.2%americanbankingnews.com - September 17 at 4:10 AMDURECT (NASDAQ:DRRX) Rating Lowered to Sell at StockNews.comamericanbankingnews.com - September 17 at 3:24 AMNorthland Securities Initiates Coverage on DURECT (NASDAQ:DRRX)americanbankingnews.com - September 16 at 3:26 AMNorthland sees DURECT's upcoming data as "major" catalyst for stockmsn.com - September 14 at 10:41 PMNorthland sees DURECT's upcoming data as "major" catalyst for stock (update)seekingalpha.com - September 14 at 5:41 PMDURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitisfinance.yahoo.com - September 7 at 11:13 AMDURECT Corporation Announces Presentations in Upcoming Investor Conferencesfinance.yahoo.com - August 31 at 6:40 PMAnalysts Offer Insights on Healthcare Companies: Durect (DRRX) and Cytokinetics (CYTK)markets.businessinsider.com - August 11 at 8:51 AMCantor Fitzgerald Maintains Durect (DRRX) Overweight Recommendationmsn.com - August 11 at 2:09 AMHC Wainwright & Co. Maintains Durect (DRRX) Buy Recommendationmsn.com - August 11 at 2:09 AMDURECT GAAP EPS of -$0.46 beats by $0.02, revenue of $2.08M misses by $1.08Mmsn.com - August 9 at 6:57 PMDURECT Corporation Reports Second Quarter 2023 Financial Results and Business Updatefinance.yahoo.com - August 9 at 6:57 PMEarnings Outlook For Durectbenzinga.com - August 8 at 6:28 PMDURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business Updatefinance.yahoo.com - August 3 at 7:47 PMU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.47%msn.com - July 20 at 6:32 PMDurect Shares Slide Premarket on Planned Stock Sale >DRRXmarketwatch.com - July 20 at 1:18 PMDURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - July 20 at 8:18 AMDURECT (NASDAQ:DRRX) Downgraded by StockNews.commarketbeat.com - July 7 at 1:17 AMDURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitisfinance.yahoo.com - June 7 at 9:47 AMConnor Clark & Lunn Investment Management Ltd. Lowers Holdings in DURECT Co. (NASDAQ:DRRX)marketbeat.com - June 5 at 6:21 AMDURECT Co. (NASDAQ:DRRX) Shares Sold by Russell Investments Group Ltd.marketbeat.com - June 2 at 4:40 AMTocqueville Asset Management L.P. Has $316,000 Position in DURECT Co. (NASDAQ:DRRX)marketbeat.com - May 19 at 7:46 AMAnalysts Offer Insights on Healthcare Companies: Durect (DRRX), Pfizer (PFE) and BioVie (BIVI)markets.businessinsider.com - May 18 at 8:46 AMCantor Fitzgerald Reiterates Durect (DRRX) Overweight Recommendationmsn.com - May 17 at 10:10 PMAnalyst Ratings for Durectmarkets.businessinsider.com - May 17 at 5:10 PM8-K: DURECT CORPmarketwatch.com - May 17 at 7:05 AMAnalysts Offer Insights on Healthcare Companies: Durect (DRRX), MacroGenics (MGNX) and Precision BioSciences (DTIL)markets.businessinsider.com - May 12 at 4:50 PMFY2023 EPS Estimates for DURECT Co. (NASDAQ:DRRX) Lowered by Cantor Fitzgeraldmarketbeat.com - May 12 at 9:40 AMWall Street Analysts Think Durect (DRRX) Could Surge 594.98%: Read This Before Placing a Betfinance.yahoo.com - May 11 at 3:51 PMDurect: Q1 Earnings Snapshotwashingtonpost.com - May 10 at 3:00 PMDURECT Corporation Reports First Quarter 2023 Financial Results and Business Updatefinance.yahoo.com - May 8 at 5:54 PMDURECT Corporation to Announce First Quarter 2023 Financial Results and Provide Business Update on May 8finance.yahoo.com - May 1 at 11:27 PMDURECT Corporation to Host KOL Event on Alcohol-Associated Hepatitisfinance.yahoo.com - April 27 at 6:29 PMDURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conferencefinance.yahoo.com - April 25 at 7:27 PMDURECT Corporation (DRRX) stock historical prices & data – Yahoo Financeuk.finance.yahoo.com - April 25 at 9:26 AMH.C. Wainwright Reaffirms Their Buy Rating on Durect (DRRX)markets.businessinsider.com - April 13 at 7:49 PMHC Wainwright & Co. Reiterates DURECT (DRRX) Buy Recommendationmsn.com - April 13 at 12:53 AMDURECT Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2a Study of Larsucosterol in Alcohol-Associated Hepatitisfinance.yahoo.com - April 10 at 8:01 AMShort Interest in DURECT Co. (NASDAQ:DRRX) Grows By 6.9%marketbeat.com - March 16 at 3:17 AMCantor Fitzgerald Weighs in on DURECT Co.'s FY2023 Earnings (NASDAQ:DRRX)marketbeat.com - March 13 at 2:32 AMDURECT Corporation (NASDAQ:DRRX) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - March 11 at 8:22 AMQ1 2023 EPS Estimates for DURECT Co. (NASDAQ:DRRX) Raised by Analystmarketbeat.com - March 10 at 6:14 AMDURECT Corporation Fireside Chat at the Oppenheimer 33rd Annual Healthcare Conferencefinance.yahoo.com - March 9 at 8:46 AMDURECT Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and AHFIRM Trial Updatefinance.yahoo.com - March 7 at 6:34 PMDurect (NASDAQ: DRRX)fool.com - January 15 at 3:10 PMDRRX.C - DURECT Corp | Stock Price & Latest News | Reutersreuters.com - January 1 at 11:25 PMDURECT Corporation (DRRX) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - December 17 at 12:28 PMDURECT (NASDAQ:DRRX) Trading Up 8.7% After Analyst Upgrademarketbeat.com - December 7 at 11:21 AMDURECT Corporation: DURECT Announces 1-for-10 Reverse Stock Splitfinanznachrichten.de - December 4 at 12:27 AM Get DURECT News Delivered to You Automatically Sign up to receive the latest news and ratings for DRRX and its competitors with MarketBeat's FREE daily newsletter. Email Address DRRX Media Mentions By Week DRRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRRX News Sentiment▼0.620.46▲Average Medical News Sentiment DRRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRRX Articles This Week▼91▲DRRX Articles Average Week Get DURECT News Delivered to You Automatically Sign up to receive the latest news and ratings for DRRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ANEB News Today PRPH News Today TLSA News Today KRON News Today AFMD News Today GTHX News Today OCUP News Today VHAQ News Today ELYM News Today ADCT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:DRRX) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DURECT Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.